Sanovel
Private Company
Funding information not available
Overview
Sanovel is a long-established, private Turkish pharmaceutical company with a core focus on generic drugs. It leverages a strong R&D infrastructure and a value-driven culture centered on agility, ethics, and environmental responsibility to serve the healthcare market. The company's strategy is built on responsible production, a broad portfolio across multiple therapeutic areas, and a commitment to continuous improvement to strengthen Turkey's pharmaceutical industry.
Technology Platform
Integrated R&D and manufacturing platform for generic pharmaceutical formulation development, bioequivalence testing, and sustainable production.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive generic drugs market, competing against both large multinational generic firms and other domestic Turkish pharmaceutical companies. Competition is primarily based on price, product portfolio breadth, manufacturing quality, and reliability of supply.